|Day Low/High||41.09 / 43.57|
|52 Wk Low/High||31.25 / 58.46|
Live Audio Webcast will be on January 9, 2017
Adam Feuerstein compiles a list of questions, thoughts, declarations, catalysts and observations about biotech stocks to help investors prepare for the year ahead.
Will Continue to Support Company Over Extended Transition Period Through End of 2017
Live Audio Webcast will be on December 14, 2016
New One Year Safety and Efficacy Data of INGREZZA in Tardive Dyskinesia Patients
Advisory Committee Meeting Scheduled for February 16, 2017
Live Audio Webcast will be on November 30, 2016
Live Audio Webcast will be on November 16, 2016
Live Audio Webcast will be on November 7, 2016
Conference Call and Webcast Scheduled For Wednesday, November 2, 2016
- Elagolix shows superiority compared to placebo in reducing daily menstrual and non-menstrual pelvic pain associated with endometriosis
The squeeze is on these stocks, and they are poised for volatile moves.
Live Audio Webcast will be on September 13, 2016
Live Audio Webcast will be on September 7, 2016
Six Month Open Label Safety and Tolerability Study of Valbenazine
The most recent short interest data has been released for the 07/15/2016 settlement date, which shows a 606,250 share increase in total short interest for Neurocrine Biosciences, Inc. , to 4,930,434, an increase of 14.02% since 06/30/2016.
Conference Call and Webcast Scheduled For Wednesday, August 3, 2016
NBIX, ZPIN, VLP, NWLI and INFO were all recently downgraded by TheStreet's Quant Ratings.
The company sans CEO Scangos needs to do some type of deal in the coming months.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ESNT, HBHC, HMY, IILG, MYCC, NEWM, PRTY, TOT, VTTI Downgrades: NBIX Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
The most recent short interest data has been released for the 06/30/2016 settlement date, which shows a 1,864,374 share decrease in total short interest for Neurocrine Biosciences, Inc. , to 4,324,184, a decrease of 30.13% since 06/15/2016.
Live Audio Webcast will be on June 8, 2016
Trade-Ideas LLC identified Neurocrine Biosciences (NBIX) as a strong on high relative volume candidate
Stocks with insider trader activity include NBIX, FRGI and LBAI